Tuesday, April 07, 2020

(Courtesy of Dor Yeshorim) Dor Yeshorim is a brand name. Its services have benefited hundreds of thousands of individuals across the globe. Its groundbreaking screening has pioneered, preserved and protected tens of thousands of healthy families, resulting in priceless joy and boundless Yiddishe nachas.

As with all brand names, the behind-the-scenes reality is even more heartwarming and impressive. Medicine and healthcare is constantly evolving. Dor Yeshorim’s cutting-edge, world-leading Institute of Research & Development keeps it ahead of the latest innovations—and indeed, often shapes them.

One such example is spinal muscular atrophy. SMA is a devastating, all-too common genetic disease that attacks the body’s muscles. SMA occurs across all ethnic groups and has no known cure. A fully reliable genetic test for SMA does not exist. Unscreened, people tragically discover that they are carriers in the hardest way possible, when it’s too late to prevent the pain.

Dor Yeshorim’s director of research and development is Dr. David Zeevi of the Translational Genomics Lab in the Medical Genetics Institute at Shaare Zedek Medical Center. “Dor Yeshorim is currently leading the global genetic industry in our research and development for a groundbreaking, highly reliable and comprehensive SMA testing method. We will not rest until we know that klal Yisrael is protected from this horrifying disease.”

Dor Yeshorim endeavors to do to SMA what it has done to tay sachs: virtually eradicate it from within our midst. With Hashem’s blessing and extensive work by Dor Yeshorim’s top-of-the line research and development department, a testing breakthrough is imminent.

Dor Yeshorim’s mission and mandate is to pioneer, protect and preserve our people, healthy generation after healthy generation.

Researching and developing current solutions for present, future, and eternal generations is one of many ways that Dor Yeshorim serves you and your family.


Join Our List
and receive information on community events, announcements, exclusive sales and our issue emails.